Representation of Foamix in a merger with Menlo
Our firm, in cooperation with the US firm Skadden, represented the Israeli company Foamix Pharmaceuticals (NASDAQ: FOMX) in a merger with the US dermatology company Menlo Therapeutics. For more info, click here.

